Skip to main content

Table 4 Clinicopathological characteristics of the 423 PTC

From: Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer

VariablesPTCs with low glycolysis signaturePTCs with high glycolysis signatureχ2* or t or H.R.§/ p-value
Gender (M:F)59:15350:1610.74*/0.389
Age (years)43 (15–89)47 (19–83)3.06/0.002
Stage
 1 / 2 / 3 / 4131 / 15 / 45 / 20119 / 23 / 48 / 200.995
 Recurrence-free survival time (months)14.59 (0–158.71)14.06 (0–157.03)1.50§/0.033
  1. p-value from Analysis of Variance
  2. PTC Papillary Thyroid Cancer; H.R Hazard Ratio
  3. Data in parentheses are ranges